Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04289363 · ClinicalTrials.gov registry record
Emergency Department Outcomes for Patients With Opioid Use Disorder
A clinical trial of Opioid Use Disorder, sponsored by NYU Langone Health.
- Completed
- Registry status
- 53
- Enrollment target
- 2
- Study locations
NCT04289363: Completed study of Opioid Use Disorder, sponsored by NYU Langone Health.
NCT04289363 is a study of Opioid Use Disorder that has completed, run by NYU Langone Health. The registered enrollment target is 53 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04289363, a study of Opioid Use Disorder, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
- 2
- Study locations
Study Summary
Using mixed methods and triangulating multiples sources of data collected over the course of the parent (CTN-0079 - NCT03544112) and the ancillary studies to evaluate the feasibility, acceptability, sustainability and impact of the emergency department (ED)-initiated Buprenorphine (BUP) clinical program and implementation facilitation strategy and identify factors influencing diffusion and effectiveness.
Primary Outcome
The outcome will be calculated using the following formula: \[(Candidates who receive ED-initiated BUP with any disposition) + (Candidates who receive ED-expedited BUP and who are discharged)\] / \[(Candidates who are discharged) + (Candidates who receive ED-initiated BUP that are not discharged)\].
Conditions Studied
Interventions
- BEHAVIORAL Clinical program implementation
Study Locations (2)
New Hampshire
- Catholic Medical Center - Manchester
New York
- Bellevue Hospital Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2020-11-25 |
| Est. Completion | 2022-02-18 |
What the finished NCT04289363 record still lists
NCT04289363 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Clinical program implementation is the first listed.
NCT04289363 reports a single indexed study location in New Hampshire, New York.
Frequently Asked Questions
What is clinical trial NCT04289363 about?
NCT04289363 is a clinical study titled "Emergency Department Outcomes for Patients With Opioid Use Disorder". Using mixed methods and triangulating multiples sources of data collected over the course of the parent (CTN-0079 - NCT03544112) and the ancillary studies to evaluate the feasibility, acceptability, sustainability and impact of the emergency department (ED)-initiated Buprenorphine (BUP) clinical pro...
What is the current status of trial NCT04289363?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2020-11-25. Estimated completion is 2022-02-18.
What conditions does trial NCT04289363 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT04289363?
The interventions under investigation include: Clinical program implementation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04289363?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04289363 being conducted?
This trial has 2 study locations across New Hampshire, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04289363's enrollment target sits among peer trials
53 170th of 257 higher than 87 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI